Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Sale of 6,250 SOPH shares, $50.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | SOPHiA GENETICS SA (SOPH) | Sale | 6,250 | $50.8K |
| Aug 26, 2026 | SOPHiA GENETICS SA (SOPH) | Sale | 6,250 | $54.2K |
| Jun 23, 2026 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 99,116 | n/a |
| Jun 22, 2026 | SOPHiA GENETICS SA (SOPH) | Grant/Award | 19,724 | $107.7K |
| May 13, 2026 | SOPHiA GENETICS SA (SOPH) | Sale | 7,508 | $35.0K |
| Jun 24, 2025 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 94,592 | n/a |
| Jul 2, 2024 | STANDARD BIOTOOLS INC. (LAB) | Grant/Award | 43,128 | n/a |
| May 21, 2024 | 23andMe Holding Co. (ME) | Tax Withholding | 35,282 | $19.3K |
| May 6, 2024 | 23andMe Holding Co. (ME) | Exercise/Conversion | 38,551 | $16.2K |
| Apr 19, 2024 | 23andMe Holding Co. (ME) | Exercise/Conversion | 38,548 | $16.2K |